Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach...
Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach to fight infection
Objective: The aim of GLYMCE is to understand how carbohydrates and their assemblies are recognized by pathogens to drive infections. The identified molecular patterns will be transferred to biomimetic glycopolymer materials to ex...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2021-123781OB-C21
DESCIFRANDO EL CODIGO DEL RECONOCIMIENTO MOLECULAR DE GLICAN...
387K€
Cerrado
Glyco-Platforms
Novel smart glyco nanomaterials as targeted therapeutics.
195K€
Cerrado
PTQ2020-011288
GLIcoconjugados POLiméricos contra Infecciones bacterianas y...
38K€
Cerrado
LECNAC
Synthetic lectins for beta GlcNAc evaluation of their poten...
181K€
Cerrado
BIO2009-08983
DESARROLLO DE UNA PLATAFORMA UNIVERSAL DE GLICOSONDAS PARA D...
97K€
Cerrado
GLYCOSENSE
Polymer brush sensing arrays for the identification of patho...
258K€
Cerrado
Información proyecto GLYMCE
Duración del proyecto: 70 meses
Fecha Inicio: 2023-03-20
Fecha Fin: 2029-01-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Objective: The aim of GLYMCE is to understand how carbohydrates and their assemblies are recognized by pathogens to drive infections. The identified molecular patterns will be transferred to biomimetic glycopolymer materials to extend the arsenal for the fight against infections.
Carbohydrates are not just sweet, they are crucial in various biological interactions: Cell surfaces are covered in carbohydrates, the glycocalyx, that governs contact with pathogens such as viruses and bacteria. A class of carbohydrates critical for pathogen attachment and infections are glycosaminoglycans (GAGs). GAGs are highly diverse polysaccharides already used in medicine (e.g., heparin against thrombosis). The potential of GAGs in fighting viral and bacterial infections has been recognized in biology and medicine, but, as of today, there are no GAG-based drugs used for this purpose. A key limitation is insufficient knowledge about the mode of action of GAGs within the complex ensemble of the glycocalyx:
How does the display of GAGs within the glycocalyx affect their pathogen interactions?
GLYMCE wGLYMCE will tackle this question from the polymer chemist’s point-of-view: taking a bottom-up approach to prepare GAG mimetics (level 1); assemble glycocalyx mimetics and study their spatial organization of GAGs upon pathogen binding (level 2); reengineer the glycocalyx of living cells to understand the factors governing infection (level 3). This is only now possible through recent synthetic tools developed by my lab enabling GAG mimetics with controlled sequence, molecular weight, chain conformation, architecture and sulfation patterns – all parameters known to critically impact the affinity and selectivity of GAGs.
Overall, by taking a radically different approach informed by chemical biology and brought to life by polymer chemistry, mechanisms for GAG-mediated pathogen attachment will be derived and applied to develop new materials and strategies to detect, prevent and treat infections.